News Headline Summary
FDA advisory panel vote 18 to 0 for J&J drug
- Data supports the efficacy of J&J drug Bedaquiline against resistant TB.
- No immediate reaction to the news, last trade at USD 69.25 (+0.65%).
20:55, 28 Nov 2012 -
Subscribe Now to RANsquawk
Click here for a 1 week free trial
RANsquawk provides audio news and commentary for over 15,000
professional traders and brokers worldwide. Services include:
Real-time audio coverage from 0630 to 2130 London time
Teams of analysts covering equities, fixed income, FX and energy markets
Real-time scrolling news service
Daily and weekly pre-market research and calendars
Intra-day market update videos
Daily technical analysis